Brand-Name and Generic Prescription Drug Use After Adoption of a Full-Replacement, Consumer-Directed Health Plan With a Health Savings Account
Year of publication: |
2014
|
---|---|
Authors: | Fronstin, Paul ; Roebuck, M. Christopher |
Publisher: |
[S.l.] : SSRN |
Subject: | Arzneimittel | Pharmaceuticals | Krankenversicherung | Health insurance | Gesundheitskosten | Health care costs | Sparen | Savings | Konsumentenverhalten | Consumer behaviour | Generika | Generic drugs | Gesundheitspolitik | Health policy |
Extent: | 1 Online-Ressource (16 p) |
---|---|
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | In: EBRI Notes, Vol. 35, No. 3 (March 2014) Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments March 2014 erstellt |
Classification: | I1 - Health ; I11 - Analysis of Health Care Markets ; J32 - Nonwage Labor Costs and Benefits; Private Pensions |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Fronstin, Paul, (2013)
-
Fronstin, Paul, (2014)
-
Impact of the Medicare Part D Coverage Gap Closure and Generic Entry on Medication Use
Kaplan, Cameron, (2020)
- More ...
-
Fronstin, Paul, (2017)
-
Fronstin, Paul, (2014)
-
Medication Utilization and Adherence in a Health Savings Account–Eligible Plan
Fronstin, Paul, (2015)
- More ...